Long-term persistence of acquired resistance to 5-fluorouracil in the colon cancer cell line SW620.

[1]  Ben S. Wittner,et al.  A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.

[2]  Huamin Wang,et al.  Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. , 2009, Cancer research.

[3]  Ling Xia,et al.  Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. , 2009, Cancer research.

[4]  D. Ito,et al.  Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest. , 2009, Oral oncology.

[5]  C. Caldas,et al.  Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells , 2009, Molecular Cancer Therapeutics.

[6]  V. O’Brien,et al.  Cell cycle perturbation and acquired 5-fluorouracil chemoresistance. , 2008, Anticancer research.

[7]  S. Echigo,et al.  Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma. , 2007, International journal of oncology.

[8]  G. Steger,et al.  Progressive up‐regulation of genes encoding DNA methyltransferases in the colorectal adenoma‐carcinoma sequence , 2007, Molecular carcinogenesis.

[9]  W. Bodmer,et al.  Cytostatic drug treatment causes seeding of gene promoter methylation , 2007, European journal of cancer.

[10]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[11]  Trond Stokke,et al.  Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery , 2006, Molecular Cancer.

[12]  M. Peinado,et al.  Genetic determinants of methotrexate responsiveness and resistance in colon cancer cells , 2005, Oncogene.

[13]  Andrei V Bakin,et al.  Silencing of the Tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-β , 2005, Oncogene.

[14]  W. Schmidt,et al.  Dissecting progressive stages of 5‐fluorouracil resistance in vitro using RNA expression profiling , 2004, International journal of cancer.

[15]  A. Rowan,et al.  Characterization of the E‐cadherin/catenin complex in colorectal carcinoma cell lines , 2004, International journal of experimental pathology.

[16]  D. Spiller,et al.  Density-dependent location and interactions of truncated APC and beta-catenin. , 2004, Oncogene.

[17]  Georg Krupitza,et al.  The evolution of cell death programs as prerequisites of multicellularity. , 2003, Mutation research.

[18]  G. Peters,et al.  Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside , 2002, Cell Death and Differentiation.

[19]  D. Fisher,et al.  A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. , 2001, Cancer research.

[20]  R. Jakesz,et al.  Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro. , 1997, Biochemical pharmacology.

[21]  S. Wong,et al.  Epigenetic mechanisms of drug resistance: drug-induced DNA hypermethylation and drug resistance. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.